1. Home
  2. NTLA vs MRTN Comparison

NTLA vs MRTN Comparison

Compare NTLA & MRTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • MRTN
  • Stock Information
  • Founded
  • NTLA 2014
  • MRTN 1946
  • Country
  • NTLA United States
  • MRTN United States
  • Employees
  • NTLA N/A
  • MRTN N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MRTN Trucking Freight/Courier Services
  • Sector
  • NTLA Health Care
  • MRTN Industrials
  • Exchange
  • NTLA Nasdaq
  • MRTN Nasdaq
  • Market Cap
  • NTLA 1.2B
  • MRTN 1.1B
  • IPO Year
  • NTLA 2016
  • MRTN 1986
  • Fundamental
  • Price
  • NTLA $10.90
  • MRTN $12.14
  • Analyst Decision
  • NTLA Buy
  • MRTN Buy
  • Analyst Count
  • NTLA 20
  • MRTN 2
  • Target Price
  • NTLA $32.30
  • MRTN $19.00
  • AVG Volume (30 Days)
  • NTLA 5.0M
  • MRTN 671.8K
  • Earning Date
  • NTLA 08-07-2025
  • MRTN 07-16-2025
  • Dividend Yield
  • NTLA N/A
  • MRTN 1.98%
  • EPS Growth
  • NTLA N/A
  • MRTN N/A
  • EPS
  • NTLA N/A
  • MRTN 0.25
  • Revenue
  • NTLA $52,857,000.00
  • MRTN $920,872,000.00
  • Revenue This Year
  • NTLA N/A
  • MRTN N/A
  • Revenue Next Year
  • NTLA N/A
  • MRTN $5.04
  • P/E Ratio
  • NTLA N/A
  • MRTN $48.47
  • Revenue Growth
  • NTLA 14.99
  • MRTN N/A
  • 52 Week Low
  • NTLA $5.90
  • MRTN $11.58
  • 52 Week High
  • NTLA $24.16
  • MRTN $18.63
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 45.06
  • MRTN 43.38
  • Support Level
  • NTLA $10.57
  • MRTN $11.58
  • Resistance Level
  • NTLA $11.51
  • MRTN $12.37
  • Average True Range (ATR)
  • NTLA 0.69
  • MRTN 0.31
  • MACD
  • NTLA -0.26
  • MRTN 0.01
  • Stochastic Oscillator
  • NTLA 10.44
  • MRTN 37.58

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About MRTN Marten Transport Ltd.

Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.

Share on Social Networks: